FORESIGHT STUDY Future Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT.

Slides:



Advertisements
Similar presentations
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Advertisements

Output analysis of AMR EU funding 5FP-6FP-7FP -Quantitative data- Coordinators of 117 AMR-related EU projects contacted, yielding 54 submissions Survey.
Combating major diseases Gender aspects in research Gender aspects in research have a particular relevance to this theme as risk factors, biological mechanisms,
Medical Diagnostics NIAID Funding Opportunities Maria Y. Giovanni, Ph.D. Assistant Director for Microbial Genomics and Advanced Technologies National Institute.
Antimicrobial resistance “One health fits all”
1 Institute of Epidemiology and Infectious Diseases Research Activities The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases Svetlana.
Towards a European VET area: Zooming in on 2010 Aviana Bulgarelli Director Cedefop.
Research & Innovation Horizon societal challenge 1 Open Info Day Funding Opportunities for SMEs Horizon 2020 "Health, demographic change and wellbeing"
The NIH Roadmap for Medical Research
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
Title of Presentation 1 EU-ASEAN S&T cooperation to jointly tackle societal challenges Opportunities for future EU-ASEAN collaborations.
Towards a global plan to fight against bioterrorism in synergy with Russian Federation Novosibirsk
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
05/09/2015www.ecrin.org1 European Clinical Research Infrastructures Network
Biomarker - Advanced Technologies & Global Markets (2009 to 2014) Markets & Markets – Analyst Briefing Research Analyst : Kandarp Saraswat Moderator: Manisha.
1 Progress report: DISCONTOOLS Project Morgane Delavergne DISCONTOOLS Project Manager, September 22nd, 2009 Mirror Group Meeting Châtelain Hotel, Brussels.
A new antivirulence approach against pathogenic bacteria A new antivirulence approach against pathogenic bacteria May 2005 Sonia Escaich - President &
Director, DG RTD, Directorate International Cooperation
Overview of current ANCS activities in relation with IMI Ioana Ispas Advisor for Bioethics, Genomics and Health ANCS.
Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
WP3 Strategic analysis of the future perspectives for cooperation and coordination Summary of the expert workshop on the European Research Agenda (WP 3)
1 Innovation and innovation policies in developing countries in the framework of PaceNet+ Ludovico Alcorta Director. Research, Statistics and Industrial.
1 EU-funded health research activities against TB: FP6 actions and perspectives toward FP7 DG Research - European Commission 22 MARCH 2007.
1 NEST New and emerging science and technology EUROPEAN COMMISSION - 6th Framework programme : Anticipating Scientific and Technological Needs.
Pathogenomics in France Philippe Glaser. Administrative situation Creation of the ANR (Agence National pour la Recherche) - National Research Agency –Delay.
The theme involve current global adoption of crop biotechnology, trends, benefits and future direction It focus on the fundamentals of KM and its current.
FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Statistics Related to Food Safety and Quality Food and Nutrition Division. FAO.
BES Equitable and Sustainable Well-being in Italy
Gerry Lawson & Pamela Kempton NERC Swindon 21 Sept Development of NERC’s next science strategy: an update for the SEERAD Strategic Science Advisory.
Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.
Specific Activities Covering a Wider Field of Research New and Emerging Science and Technology IGLO, December 2003 New and Emerging Science and Technology.
LEONARDO DA VINCI PROGRAMME PL/04/B/F/PP – _________________________________________________________________________ European Curricula for Economic.
The ORPHANET Database: A Free Online Tool for Molecular Geneticists & Cytogeneticists Emma Gillaspy
NIH ROADMAP FOR MEDICAL RESEARCH RESEARCH TEAMS OF THE FUTURE.
Presentation CESAER seminar, Trondheim Eva Camerer Policy Officer, Industrial Innovation Policy Development DG Enterprise and Industry 15 October 2010.
PUTTING THE PATIENT AT THE CENTER OF HEALTHCARE RESEARCH Towards a more inclusive model.
Valentina Di Francesco Senior Program Officer for Bioinformatics, Structural Genomics and Systems Biology Microbial Genomics.
LOCAL PASS A Local approach towards the reduction of PsychoActive Substance uSe Renée Otte February 5, 2015.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Strategy for the assessment of information on DDT John Githure.
ESI workshop Stochastic Effects in Microbial Infection The National e-Science Centre Edinburgh September 28-29, 2010.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Second International Seville Seminar on Future-Oriented Technology Analysis (FTA): Impacts on policy and decision making 28th- 29th September 2006 The.
HORIZON 2020 SC1-Health, demographic change and wellbeing challenge Марина Николовска Министерство за образование и наука
GLOBAL MARKET TRENDS The view from Pharma By Peter Knauer Executive Partner, Alliance Partnership.
Transport Programme Committee Arnoldas Milukas HoU Horizontal aspects and coordination DG RTD, Transport directorate 20 October 2010.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Major / Minor Technology and Entrepreneurship (HIR/BEng) March 16, 2016.
Current Status and Next Steps. DISCONTOOLS, Rome, April ‘16.
I farmaci innovativi in una prospettiva europea Giuseppe M.C. Rosano, MD, PhD Cardiovascular and Cell Sciences Research Institute, St George's University.
A European Academic Network for Vaccine Research An Idea from the Danish Mirror Group under ETPGAH Working group: Jens Kjær – Boehringer Ingelheim DK Poul.
Anne-Marie Yazbeck, PhD National Infoday, Sweden 2017
Research on Antimicrobial Resistance
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Work Programme The social challenge “Health, Demographic Change and Wellbeing” Maia Okujava NCP for Health, Demographic Change and weii-being,
A new antivirulence approach against pathogenic bacteria
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Call topic identification for 2019 call
Impact of JPIAMR funded projects: Strategy development
The Role of NICs in Influenza Surveillance
The International Consortium for Personalised Medicine
JPIAMR Joint Research Calls – Update and Future Calls
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
SRIA Roadmap Jonathan Pearce
Horizon 2020 EarLy dEtection of cerVical cAncer in hard-to-reach populations: development and implementation of a new HPV test combining self-sampling.
Yelena Shevchenko Director of Strategic Planning and
Presentation transcript:

FORESIGHT STUDY Future Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT

Overview on future trends and challenges in research on human-pathogenic microorganisms (bacteria & fungi) –Developments in basic research –Diagnostics & therapy –Public health –Research co-operations –Technology transfer & market development OBJECTIVES

Methods –Literature & internet research –Preliminary assessment –Expert survey Results –Research foci Methods, diagnostics & therapeutics –Challenges for research –Public health –Co-operations –Market development & technology transfer Recommendations Discussion STRUCTURE

Triangulation: combination of literature and internet research with expert survey & interviews "Triangulation [...] reduces the risk of systematic distortions inherent in the use of only one method.“ METHODS Maxwell 1998

Databases –PubMed –Medline –Important scientific journals Keywords & combinations –pathogenomics, infectious disease, public health, bacteria, fungi, bioweapons, bioterrorism and/or human-pathogenic Focus on reviews –Specialised articles on particular micro-organisms were excluded METHODS: Literature Research

Internet research on national & international –Surveys –Experts –Institutions –Networks METHODS: Internet Research

Addressee: –62 members of the ERA-NET PathoGenoMics from 17 countries Questions –Contact partners and national institutions –National main foci in microbiological research –National newly emerging hot topics in pathogenomics –Existing foresight studies on pathogenomics or related subjects METHODS: Preliminary Assessment

Development and application of questionnaires with questions on –Basic research –Future prospects in diagnostics & therapy –Strengths and weaknesses in research –Important cooperations and projects –Technology transfer & market development –Public health METHODS: Expert Survey

A total of 329 experts was selected and contacted.

METHODS: Expert Survey Table 1: Reply & return rates

RESULTS: Research Foci

RESULTS: Trends in Methodology Improvement of conventional methods – Microscopy – Serology Novel technologies – High-throughput analyses – Real time approaches – Bioinformatics – Omic‘s

RESULTS: Trends in Omic`s Systemic approach Genomics Proteomics Transcriptomics Metabolomics

RESULTS: Trends in Omic`s Genomics Transcriptomics Proteomics Metabolomics Understanding of: Infection Pathogenesis

RESULTS: Trends in Diagnostics Use of novel technologies –PCR –Sequence-based identification –Molecular strain typing But tools need to be more... – rapid – sensitive – specific – robust – affordable

RESULTS: Challenges for Therapeutics Extension of databases & discovery of molecular strategies In order to... –enable comprehensive statistical and comparative analyses –standardise & validate diagnostics –find novel targets –develop new vaccines –innovate antibiotic intervention –individualise therapy

RESULTS: Challenges for Research Multidisciplinary research on –Ecology & environment –Population dynamics –Evolution & taxonomy –Epidemiology –Risk assessment

RESULTS: Challenges for Research Basic research on infection & pathogenesis –Analysis of host-pathogen-interaction –Identification of signaling pathways –Analysis of metabolic interactions –Identification of virulence factors –Target identification –...

Major risks are –Multidrug resistance (cf. tuberculosis) –Nosocomial infections –Bioterrorism RESULTS: Public Health - Risks „ Infectious diseases account for [...] 25 % of global deaths (over 14 million deaths annually)“ (WHO 2000)

Surveillance systems Action plans for emergencies Vaccination strategies Rapid and early diagnostics RESULTS: Public Health Measures

RESULTS: Co-operations What are the most important research partners for scientists in pathogenomics? Table 2: Co-operations and global players (N=30)

Barriers –High R&D costs –Limited market size for vaccines and antibiotic products compared to the market for diseases of civilisation Opportunities –Public-private partnerships –Subcontracting with SME`s for preclinical studies –Public funding for orphan drugs RESULTS: Market Development & Technology Transfer

1. Establish a European surveillance system 2. Reduce the misuse of pesticides in agriculture and animal technology 3.Create a European Competence Center for epidemiological research and modelling 4. Create an R&D programme that is specifically tailored to support public-private partnerships 5. Create structures for early warning and rapid response to emergencies RECOMMENDATIONS

6. Develop comparative risk assessment strategies for setting national health priorities 7. Reconsider work-sharing between research institutes and universities 8. Foster cooperations between microbiological researchers and clinicians 9. Foster inclusion of ecological aspects into microbiology 10. Improve transparency about the function of different networks on pathogenomics 11. Conduct a study on industrial research objectives and economic interests RECOMMENDATIONS

THANK YOU VERY MUCH FOR YOUR ATTENTION! The complete report on FUTURE TRENDS AND CHALLENGES IN PATHOGENOMICS will soon be available at

1. Establish a European surveillance system 2. Reduce the misuse of pesticides in agriculture and animal technology 3.Create a European Competence Center for epidemiological research and modelling 4. Create an R&D programme that is specifically tailored to support public-private partnerships 5. Create structures for early warning and rapid response to emergencies 6. Develop comparative risk assessment strategies for setting national health priorities 7. Reconsider work-sharing between research institutes and universities 8. Foster cooperations between microbiological researchers and clinicians 9. Foster inclusion of ecological aspects into microbiology 10. Improve transparency about the function of different networks on pathogenomics 11. Conduct a study on industrial research objectives and economic interests RECOMMENDATIONS